Tongling Jieya Biologic Technology (301108.SZ) issued a profit warning, estimating a net profit of 15 million to 22.5 million yuan for the year 2024, a year-on-year decrease of 86.98% to 80.47%.

23/01/2025

GMT Eight

Tongling Jieya Biologic Technology (301108.SZ) released its 2024 annual performance forecast, with the company expecting a net profit attributable to shareholders of the listed company of 15-22.5 million yuan in 2024, a year-on-year decrease of 86.98%-80.47%.

Webray Tech (688651.SH) has issued a profit warning, expecting a net profit of 20-27.5 million yuan in 2024, a decrease of 35.31% to 52.95% compared to the previous year.

Hob Biotech Group Corp., Ltd(688656.SH): The deadline for the tender offer has expired and trading will resume on January 24th.

Contact: contact@gmteight.com

Tongling Jieya Biologic Technology (301108.SZ) issued a profit warning, estimating a net profit of 15 million to 22.5 million yuan for the year 2024, a year-on-year decrease of 86.98% to 80.47%.

RECOMMEND

HK Stock Market Move | Chip stocks rally across the board Semiconductor companies intensively disclose performance pre-earnings beats. Institutions claim that localization remains the core growth logic.

HK Stock Market Move |

HK Stock Market Move | TRIP.COM-S (09961) rose more than 4% with high certainty of increased consumption for the Spring Festival travel. Inbound tourism business may serve as a strong catalyst for the company.